New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export MRK’s income statement to Excel — free account
Merck & Co., Inc.
MRKHealthcare Drug Manufacturers General
Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.
- Revenue
- +4.68%
- EPS
- −12.1%
- Free cash flow
- −19.3%
- Total debt
- +24.3%
Quarter to September 2026, against a year earlier
134.93
2.19
+1.65%
Follow MRK
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Dividends and buybacks of $13.2B were more than free cash flow of $12.4B; $11.4B of new borrowing made up the difference. Cash rose by $1.4B. What is a cash flow statement?
- Free cash flow
- $12.4B 75.0% of operating cash flow
- Returned to shareholders
- $13.2B 106.5% of free cash flow
- Debt, net
- $11.4B borrowed
- Change in cash
- +$1.4B over the period
| Operating cash flow | 16.5 |
|---|---|
| Capital expenditures | −4.1 |
| Free cash flow | 12.4 |
| Acquisitions, net | −10.0 |
| From investments, net | +0.5 |
| Dividends | −8.2 |
| Buybacks, net | −5.0 |
| Debt raised, net | +11.4 |
| Other | +0.4 |
| Change in cash | 1.4 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.4B | $6.5B | $10.9B | $8.9B | $7.6B | $13.1B | $19.1B | $13.0B | $21.5B | $16.5B |
| Capex | −$1.6B | −$1.9B | −$2.6B | −$3.4B | −$4.4B | −$4.4B | −$4.4B | −$3.9B | −$3.4B | −$4.1B |
| Free cash flow | $8.8B | $4.6B | $8.3B | $5.5B | $3.2B | $8.7B | $14.7B | $9.1B | $18.1B | $12.4B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
18,263.00 | 17,133.00 | 377.00 | 14,526.00 | 12,358.00 | 4,523.00 | 5,606.00 | 6,193.00 | 2,418.00 | 3,941.00 |
Depreciation & Amortization |
5,838.00 | 4,499.00 | 3,872.00 | 3,909.00 | 3,214.00 | 3,486.00 | 3,310.00 | 4,519.00 | 4,676.00 | 5,471.00 |
Non Cash Items (Other) |
(1,164.00) | 2,993.00 | 10,607.00 | 2,141.00 | 584.00 | 2,915.00 | 1,691.00 | 785.00 | 4,184.00 | 3,352.00 |
Accounts Receivable Change |
(1,090.00) | (244.00) | (1,148.00) | (644.00) | (2,033.00) | (1,002.00) | 92.00 | (418.00) | 297.00 | (619.00) |
Change in inventories |
(1,180.00) | (835.00) | (816.00) | (161.00) | (674.00) | (895.00) | (473.00) | (911.00) | (145.00) | 206.00 |
Accounts Payable Change |
110.00 | 182.00 | (380.00) | (289.00) | 405.00 | 684.00 | 443.00 | 230.00 | 254.00 | 278.00 |
Change in payables and accrued liability |
(1,841.00) | (2,328.00) | 1,783.00 | (50.00) | 277.00 | (1,152.00) | 413.00 | (341.00) | (922.00) | (2,018.00) |
Income tax paid |
137.00 | 1,023.00 | 214.00 | 380.00 | (540.00) | 814.00 | (1,889.00) | 827.00 | (3,291.00) | 124.00 |
Change in other assets and liabilities |
(3,112.00) | (1,465.00) | (1,858.00) | (2,018.00) | (1,274.00) | (3,050.00) | (663.00) | (940.00) | (1,210.00) | (572.00) |
Other operating activities |
511.00 | 510.00 | 355.00 | 1,301.00 | 805.00 | 1,294.00 | 354.00 | 978.00 | 190.00 | 213.00 |
Operating Cash Flow |
16,472.00 | 21,468.00 | 13,006.00 | 19,095.00 | 13,122.00 | 7,617.00 | 8,884.00 | 10,922.00 | 6,451.00 | 10,376.00 |
Capital expenditures |
(4,112.00) | (3,372.00) | (3,863.00) | (4,388.00) | (4,448.00) | (4,429.00) | (3,369.00) | (2,615.00) | (1,888.00) | (1,614.00) |
Net Aquisitions |
(10,042.00) | (4,093.00) | (12,032.00) | (121.00) | (12,907.00) | (6,606.00) | (4,954.00) | (431.00) | (396.00) | (780.00) |
Short Term Investments Change (Net) |
471.00 | (142.00) | 703.00 | (483.00) | 1,025.00 | 2,717.00 | 5,420.00 | 7,258.00 | 4,925.00 | (1,298.00) |
Long-Term Investments Change (Net) |
— | — | 1,145.00 | — | — | — | — | — | — | — |
Other investing activities |
(58.00) | (127.00) | (36.00) | (89.00) | (91.00) | (875.00) | 374.00 | 102.00 | 38.00 | 482.00 |
Investing cash flow |
(13,741.00) | (7,734.00) | (14,083.00) | (4,960.00) | (16,421.00) | (9,193.00) | (2,529.00) | 4,314.00 | 2,679.00 | (3,210.00) |
Repayment/Issuance of Debt (Net) |
11,377.00 | 2,309.00 | 4,184.00 | (2,251.00) | 1,631.00 | 5,011.00 | 1,248.00 | 837.00 | (1,129.00) | (1,307.00) |
Equity Repurchase (Common, Net) |
(4,992.00) | (1,129.00) | (1,221.00) | 384.00 | (638.00) | (1,192.00) | (4,419.00) | (8,500.00) | (3,515.00) | (2,495.00) |
Dividends Paid (Total) |
(8,176.00) | (7,840.00) | (7,445.00) | (7,012.00) | (6,610.00) | (6,215.00) | (5,695.00) | (5,172.00) | (5,167.00) | (5,124.00) |
Other financial activities |
(131.00) | (372.00) | (328.00) | (240.00) | 8,714.00 | (436.00) | 5.00 | (325.00) | (195.00) | (118.00) |
Financing cash flow |
(1,922.00) | (7,032.00) | (4,810.00) | (9,119.00) | 3,097.00 | (2,832.00) | (8,861.00) | (13,160.00) | (10,006.00) | (9,044.00) |
Exchange Rate Adjustment |
563.00 | (293.00) | 23.00 | (410.00) | (133.00) | 253.00 | 17.00 | (205.00) | 457.00 | (131.00) |
Discontinued Operations and Adjustments |
— | — | — | — | 349.00 | 2,386.00 | 4,456.00 | — | — | — |
Change in Cash |
1,372.00 | 6,409.00 | (5,864.00) | 4,606.00 | 14.00 | (1,769.00) | 1,967.00 | 1,871.00 | (419.00) | (2,009.00) |
Beginning Cash |
13,318.00 | 6,909.00 | 12,773.00 | 8,167.00 | 8,153.00 | 9,934.00 | 7,967.00 | 6,096.00 | 6,515.00 | 8,524.00 |
Ending Cash |
14,690.00 | 13,318.00 | 6,909.00 | 12,773.00 | 8,167.00 | 8,165.00 | 9,934.00 | 7,967.00 | 6,096.00 | 6,515.00 |
Stock Based Compensation |
820.00 | 761.00 | 645.00 | 541.00 | 479.00 | 441.00 | 388.00 | 348.00 | 312.00 | 300.00 |
Dividends Paid (Common) |
(8,176.00) | (7,840.00) | (7,445.00) | (7,012.00) | (6,610.00) | (6,215.00) | (5,695.00) | (5,172.00) | (5,167.00) | (5,124.00) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(6,976.00) | (3,667.00) | (2,205.00) | (2,782.00) | (3,839.00) | (4,601.00) | (2,077.00) | (1,553.00) | (5,017.00) | (2,601.00) |
Investments Change (Net) |
471.00 | (142.00) | 1,848.00 | (483.00) | 1,025.00 | 2,717.00 | 5,420.00 | 7,258.00 | 4,925.00 | (1,298.00) |
Issuance/Purchase of Shares |
(4,992.00) | (1,129.00) | (1,221.00) | 384.00 | (638.00) | (1,192.00) | (4,419.00) | (8,500.00) | (3,515.00) | (2,495.00) |
| Other line items | ||||||||||
Revenue per Employee |
0.87 | 0.86 | 0.83 | 0.86 | 0.72 | 0.56 | 0.55 | 0.61 | 0.58 | 0.59 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026